Hematopoietic stem cell transplantation (HSCT) is the only treatment option for the hematological manifestations of Fanconi anemia (FA). Fludarabine based reduced intensity conditioning regimens have helped in improving outcomes significantly in FA patients. We retrospectively analyzed the outcomes of FA patients who underwent allogeneic HSCT at BLK Superspeciality Hospital, New Delhi from June 2011 to September 2019. Twenty FA patients underwent 23 transplants at our center. Overall survival and disease free survival were 65% and 50%, respectively at a median of 23 months. Overall mortality was 30%. HSCT for FA is a feasible option even in developing countries although children present late to transplant centers after multiple transfusions and infections.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Hematopoietic stem cell transplant
Acute myeloid leukemia
Disease free survival
European Bone Marrow Transplant
Graft versus host disease
Auerbach AD (2009) Fanconi anaemia and its diagnosis. Mutat Res 668:4–10
Wagner JE, Eapen M, MacMillan ML et al (2007) Unrelated donor bone marrow transplantation for the treatment of Fanconi anaemia. Blood 10:2256–2262
MacMillan ML, Wagner JE (2010) Haematopoeitic cell transplantation for Fanconi anaemia—When and how? Br J Haematol 149:14–21
de Latour RP, Porcher R et al (2013) Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the EBMT experience. Blood 01:479733
Benajiba L, Salvado C, Dalle JH et al (2015) HLA-matched related-donor HSCT in Fanconi anemia patients conditioned with cyclophosphamide and fludarabine. Blood 125(2):417–418
Smetsers SE, Smiers FJ et al (2016) Four decades of stem cell transplantation for Fanconi anaemia in the Netherlands. Br J Haematol 174:952–961
Locatelli F, Zecca M et al (2007) The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group. Haematologica 92:1381–1388
Ayas M (2017) Hematopoietic cell transplantation in Fanconi anemia and dyskeratosis congenita: a mini review. Hematol Oncol Stem Cell Ther 10:285–289
Ebens CL, MacMillan ML, Wagner JE (2017) Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations. Expert Rev Hematol 10(1):81–97
Conflict of interest
All authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Doval, D., Choudhary, D., Sharma, S.K. et al. Hematopoietic Stem Cell Transplantation for Fanconi Anemia: A Single Center Experience from India. Indian J Hematol Blood Transfus 36, 565–568 (2020). https://doi.org/10.1007/s12288-020-01254-3
- Fanconi anemia
- Matched sibling donor